Jonathan J Havel

7PUBLICATIONS
29CO-AUTHORS
Cancer cell biologyInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 23, 2023
Non-cell-autonomous cancer progression from chromosomal instability.

Jun Li, Melissa J Hubisz, Ethan M Earlie

|Mar 06, 2021
Qa-1b Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.

Xiao Zhang, Erich Sabio, Chirag Krishna

|Nov 28, 2019
MEK Inhibitors in Lung Cancer-You Can Teach an Old Drug New Tricks.

Jonathan J Havel

|May 04, 2019
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.

Rajarsi Mandal, Robert M Samstein, Ken-Wing Lee

|Apr 24, 2019
Immunogenic neoantigens derived from gene fusions stimulate T cell responses.

Wei Yang, Ken-Wing Lee, Raghvendra M Srivastava

|Feb 14, 2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.

Jonathan J Havel, Diego Chowell, Timothy A Chan

Pageof 2

Frequent Collaborators

3 joint publications

Timothy A Chan

2 joint publications

Ken-Wing Lee

2 joint publications

Fengshen Kuo

2 joint publications

Luc Gt Morris